Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Fluvoxamine and Smoking on AZD4635 PK
NCT04478513Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of imaradenant in solid tumor (2 arms), sponsored by AstraZeneca. Primary endpoints: Area under the plasma concentration-time curve from time zero to infinity, Area under the plasma concentration-time curve from time zero to last quantifiable concentration and 1 more. Started Jul 2020; status: completed.
02
Drugs
imaradenant
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04478513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478513.